Dr Richard Hopkins is an experienced bio-pharmaceutical executive with over 20 years in corporate leadership roles with public biotechnology companies. Dr Hopkins recently served as the managing director for Zelira Therapeutics (ASX: ZLD), a leading global company focused on clinical validation of medical cannabis. Prior to this, Dr Hopkins served as chief executive officer at PharmAust (ASX: PAA) where he oversaw clinical development of a novel cancer therapy for dogs and humans. He was also co-founder and managing director at Phylogica (ASX: PYC), where, in addition to the chief executive officer role, he served in a variate of positions, including chief scientific officer and chief operating officer.
Meet the rest of our team!
With the roots of our company lying in the neurological research field, our team is built from strong academic knowledge gained at prestigious institutions such as Princeton University and Erasmus MC.
.png)
